Table 3.
Treatments | MI ± SDa | Number of chromosome aberration | TGAP ± SDa | TGEP ± SDa | MN ± SDa | NDI ± SDa | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
CG | ICG | CB | ICB | EXC | SE | PLV | ||||||
Negative control | 8.62 ± 2.24 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0.02 ± 0.02 | 0.00 ± 0.00 | 13.10 ± 0.86 | 1.20 ± 0.05 |
Solvent control (DMSO) | 8.04 ± 0.61 | 58 | 4 | 12 | 16 | 0 | 0 | 0 | 1.06 ± 0.22 | 0.48 ± 0.09 | 18.60 ± 0.66 | 1.41 ± 0.06 |
125 μg/ml PSE | 7.72 ± 0.42 | 105 | 36 | 22 | 40 | 0 | 5 | 0 | 1.43 ± 0.32 | 0.72 ± 0.15 | 19.80 ± 0.49 | 1.37 ± 0.07 |
250 μg/ml PSE | 7.14 ± 0.35 | 68 | 17 | 28 | 58 | 0 | 15 | 0 | 1.76 ± 0.33* | 0.97 ± 0.24** | 19.88 ± 2.46 | 1.30 ± 0.08 |
500 μg/ml PSE | 6.59 ± 0.29 | 82 | 29 | 46 | 40 | 2 | 19 | 0 | 1.91 ± 0.36** | 0.88 ± 0.19* | 25.18 ± 5.71* | 1.12 ± 0.03*** |
Positive control (EMS) | 3.34 ± 1.92 | 38 | 24 | 26 | 12 | 21 | 2 | 7 | 1.61 ± 0.37b | 0.66 ± 0.19b | 34.05 ± 2.12c | 1.09 ± 0.34d |
CG chromatid gap, ICG iso-chromatid gap, CB chromatid break, ICB iso-chromatid break, EXC exchange figure, SE spiralization error, PLV pulverization, MI mitotic index, TGAP total chromosome aberration including gaps and pulverizations, TGEP total chromosome aberration excluding gaps and pulverizations, MN micronuclei frequency (%), NDI nuclear division index, PSE Parmelia sulcata methanolic extract, SD standard deviation, DMSO 50 % dimethyl sulphoxide as solvent control, EMS methyl methane sulphonate as positive control (1,250 μg/ml). Distilled water as negative control
aSignificancy of PSE doses compared with DMSO solvent control at * p < 0.05; ** p < 0.005; *** p < 0.001
bSignificancy of EMS compared with negative control at p < 0.05
cSignificancy of EMS compared with negative control at p < 0.005
dSignificancy of EMS compared with negative control at p < 0.001